Case report reveals pulmonary tumor thrombotic microangiopathy severity in a patient with malignancy, highlighting the need for careful diagnosis.
Pulmonary tumor thrombotic microangiopathy (PTTM) is a rare malignancy-associated condition characterized by progressively worsening dyspnea, dry cough, hypoxemia, pulmonary hypertension, right-sided heart failure, and sudden death. A 60-year-old female presented with intermittent dry cough, dyspnea, and chest pain. The patient was suspected of having PTTM with a pancreatic primary malignancy, based on admission findings including percutaneous oxygen saturation of 88%, respiratory alkalosis on blood-gas analysis, and elevated levels of d-dimer, NT-proBNP, and multiple tumor markers, combined with computed tomography angiography results showing enlarged lymph nodes (mediastinum, bilateral hila, right cardiophrenic angle, retroperitoneum) and a blurred peripancreatic space. Diagnostic investigations included physical examination, blood-gas analysis, laboratory tests (d-dimer, NT-proBNP, tumor markers), and computed tomography angiography of thoracic/abdominal vessels. (No therapeutic interventions detailed). The patient experienced 4 episodes of sudden clinical deterioration, suffered cardiac arrest, and died 9 days after admission. Autopsy was declined by the family. PTTM must be considered in the differential diagnosis for patients presenting with dyspnea and new-onset severe pulmonary hypertension without other obvious etiology, particularly when malignancy is suspected.
No takes yet. Share an insight, caveat, or question.
Yao et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: